EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSELUG00000012567
Gene Symbol: LTA4H
1 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSELUG00000027762
Gene Symbol: LOC105021799
3 Cross references
166 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSELUG00000006489
Gene Symbol: LOC105007988
3 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSELUG00000031471
Gene Symbol: LTB4R2B
1 Cross references
166 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor

Ensembl ID : ENSELUG00000002850
Gene Symbol: LOC105006175
4 Cross references
201 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSELUG00000014749
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a

Ensembl ID : ENSELUG00000023614
Gene Symbol: LOC105017050
3 Cross references
210 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSELUG00000004975
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1

Ensembl ID : ENSELUG00000016580
Gene Symbol: LOC105025838
3 Cross references
207 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSELUG00000016939
Gene Symbol: MIF
3 Cross references
231 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSELUG00000022848
Gene Symbol: LOC105009497
2 Cross references
196 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSELUG00000004158
Gene Symbol: LOC105031614
2 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).